Results 301 to 310 of about 150,657 (357)
Vaccine-induced donor-specific HLA antibodies: a case report highlighting sensitization risks in renal transplant waitlisted patients. [PDF]
Kakodkar P+6 more
europepmc +1 more source
This manuscript provides a comprehensive overview of the state‐of‐the‐art in non‐viral CAR‐NK cell engineering, highlighting its potential to revolutionise cancer treatment. ABSTRACT The recent advancements in cancer immunotherapy have spotlighted the potential of natural killer (NK) cells, particularly chimeric antigen receptor (CAR)–transduced NK ...
Zhaokai Zhou+18 more
wiley +1 more source
Canine intestinal organoids as a platform for studying MHC class II expression in epithelial cells. [PDF]
Nakazawa M, Nagao I, Ambrosini YM.
europepmc +1 more source
Genetically Engineered Hypoimmune Human Muscle Progenitor Cells Can Reduce Immune Rejection
Cells face two challenges after transplantation: recognition and killing by lymphocytes, and cell apoptosis induced by the transplantation environment. Our hypoimmune cells aim to address these two challenges through editing of immunomodulatory proteins and overexpression of anti‐apoptotic proteins.
Yu Chen+8 more
wiley +1 more source
Editorial: Novel applications of epitope biology to improve outcomes in transplantation. [PDF]
Lan JH, Liwski R, Lima ACM, Tafulo S.
europepmc +1 more source
We generated immune‐tolerant mature hESC‐RPE cells by overexpressing PD‐L1. PD‐L1‐expressing hESC‐RPE grafts exhibited significantly higher survival, reduced apoptosis and enhanced visual protection in retinal degeneration models, which presents an alternative target to improve the efficiency of hESC‐RPE‐based therapy for AMD. ABSTRACT Immune rejection
Bowen Li+11 more
wiley +1 more source
This article elaborates on the role of NK cells in early pregnancy from multiple perspectives, including molecular mechanisms and therapeutic interventions. It also discusses how NK cell dysfunction contributes to RSA and RIF, aiming to provide insights for future research on NK cell mechanisms and clinical treatment of RSA and RIF.
Defeng Guan+5 more
wiley +1 more source
Editorial: Community series in the role of CD1- and MR1-restricted T cells in immunity and disease, volume II. [PDF]
Iwabuchi K, Van Kaer L.
europepmc +1 more source
Genetic Polymorphisms in MHC Classes I and II Predict Outcomes in Metastatic Colorectal Cancer. [PDF]
Mittal P+15 more
europepmc +1 more source